Can’t help noticing CBM is off a cool 9% today. They don’t report earnings until Thursday before opening, and the only news I see is last night’s release of a report titled, “Global Biotech API Consumption 2016 Market Research Report”:
The report contains profiles of many industry players (including Cambrex) with sales volumes, revenues, margins and market share. But it costs $4,000 for an individual user copy (which is more than I have invested in CBM!). Any Fools out there have access to this report? Any nuggets/highlights you can share to give us a hint on whether this is a massive overreaction before earnings or a preview of bad news to come on Thursday and in the future?
It’s one level of frustration to take a serious beating for the 4th earnings season in a row; it’s another to take the beating without even knowing from where the blows are coming.
They call me,